Filing Details
- Accession Number:
- 0001209191-20-037226
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2020-06-17 16:05:49
- Reporting Period:
- 2020-06-15
- Accepted Time:
- 2020-06-17 16:05:49
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1503802 | Karyopharm Therapeutics Inc. | KPTI | Pharmaceutical Preparations (2834) | 263931704 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1588438 | Sharon Shacham | C/O Karyopharm Therapeutics Inc. 85 Wells Avenue Newton MA 02459 | President & Cso | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2020-06-15 | 7,143 | $0.03 | 763,632 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2020-06-15 | 7,143 | $16.38 | 756,489 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2020-06-15 | 357 | $0.03 | 756,846 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2020-06-15 | 357 | $16.20 | 756,489 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (right to buy) | Disposition | 2020-06-15 | 7,143 | $0.00 | 7,143 | $0.03 |
| Common Stock | Stock Option (right to buy) | Disposition | 2020-06-15 | 357 | $0.00 | 357 | $0.03 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 16,424 | 2020-10-31 | No | 4 | M | Direct | |
| 0 | 2020-10-21 | No | 4 | M | Direct |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Common Stock | 555,122 | Indirect | By Spouse |
Footnotes
- These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.
- Represents the weighted average sale price. These shares were sold in multiple transactions at prices ranging from $16.12 to $16.58, inclusive. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
- This option, representing a right to purchase a specified number of shares, vested as to 25% of the shares on November 1, 2011, and the remaining 75% vested in 36 equal monthly installments thereafter.
- This option, representing a right to purchase a specified number of shares, vested as to 25% of the shares on October 22, 2011, and the remaining 75% vested in 36 equal monthly installments thereafter.
Billionaire Hedge Funds
